Commission Regulation (EC) No 1048/2005 of 13 June 2005 amending Regulation (EC) No 2032/2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)

of 13 June 2005

amending Regulation (EC) No 2032/2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

(Text with EEA relevance)

Preamble

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market ¹ , and in particular Article 16(2) thereof,

Whereas:

(1) Article 4 of Commission Regulation (EC) No 2032/2003 ² lays down that, from the date of entry into force, any existing active substance not listed in Annex I to that Regulation is to be considered as not having been placed on the market for biocidal purposes before 14 May 2000. As a consequence biocidal products containing active substances not listed in Annex I may no longer be placed on the market, unless inclusion into Annex I or IA to Directive 98/8/EC is applied for in accordance with Article 11 of that Directive, and provisional authorisation has been received in accordance with Article 15(2) of that Directive. However, a limited number of active substances have been detected by the Member States which were not identified or notified before the time limit laid down in Commission Regulations (EC) No 1896/2000 ³ and (EC) No 1687/2002 ⁴ although there is evidence they were contained in biocidal products placed on the market before 14 May 2000. Some of these active substances are important from a socioeconomic perspective or for protection of public health. It is therefore appropriate to draw up a further list of active substances that should be allowed to remain on the market until 1 September 2006.

(2) Certain substances not included in Annex II to Regulation (EC) No 2032/2003 are applied in uses for which Member States claim that there is evidence demonstrating the essential need for reasons of health, safety, and protection of cultural heritage, or the use is critical for the functioning of society in the absence of technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment or health. It is therefore appropriate to introduce a system for applying for an extension of the period for marketing of biocidal products containing those substances. Such extensions should only be granted for the requesting Member States if the requests are justified, continued use does not give rise to concerns for human health and the environment, and, where appropriate, alternatives are being developed. The extension should only be allowed until 14 May 2010 at the latest.

(3) In accordance with Article 4(2) of Regulation (EC) No 2032/2003, placing on the market of biocidal products containing active substances not notified, or not notified for the appropriate product types, has to stop on 1 September 2006 at the latest. For certain substances or substance/product type combinations that have so far not been notified, there is now an interest by economic operators to prepare complete dossiers in view of their inclusion into Annex I or IA to Directive 98/8/EC. It is therefore appropriate, to introduce the possibility to prolong the marketing deadline for biocidal products containing such substances, in the product type concerned, provided interested operators submit complete dossiers well before 1 September 2006. If these dossiers are accepted, an extension of the period for placing those products on the market in the product types concerned should be allowed until the end of the evaluation of the complete dossiers, which should take place in parallel with the evaluation of the notified substances for the product types concerned.

(4) The task of evaluation should be distributed among the competent authorities of all Member States. Annex V to Regulation (EC) No 2032/2003 so far only designates the Rapporteur Member States for certain active substance/product type combinations. It is therefore necessary to designate the Rapporteur Member States for the remaining product types, taking into account also the accession of the new Member States on 1 May 2004. The list of competent authorities should also be adapted accordingly.

(5) Economic operators have expressed an interest in taking over the role of participants following the publication by the Commission of those cases where for a given active substance/product type combination, all participants have withdrawn or have failed to comply with their obligations. This has happened for three substances and it is therefore appropriate to list those substances, together with the designated Rapporteur Member States and the new deadlines for submission of the complete dossiers in a separate Annex.

(6) For a number of notified existing active substances/product type combinations — in particular those notified for product types 8 and 14 — all participants have withdrawn or not complied with their obligations, and no other economic operator or Member State has expressed an interest to take over the role of participants within the given deadlines. Furthermore, following the recent classification by the competent authorities and the Commission of certain milk hygiene products as biocidal products in product type 3 as defined in Annex V to Directive 98/8/EC, it is appropriate to include into Annex II certain substances used in those milk hygiene products where producers, formulators or associations believing that these were not concerned by Directive 98/8/EC did not submit notifications before the deadlines established by Regulations (EC) No 1896/2000 and (EC) No 1687/2002, but have done so before the adoption of this Regulation. Annexes II and III to Regulation (EC) No 2032/2003 should therefore be amended accordingly. Annex V, Parts A, B, C, and D, and Annex VI should also be amended in the light of the provisions contained in this Regulation.

(7) For one substance listed in Annexes I and II to Regulation (EC) No 2032/2003 an incorrect CAS number and for another one an erroneous common name are indicated. Four substances are not listed in Annexes I and III, although they were identified within the deadlines set by Regulation (EC) No 1896/2000. This should be rectified.

(8) Regulation (EC) No 2032/2003 should therefore be amended accordingly.

(9) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EC) No 2032/2003 is amended as follows:

1. The title of Article 3 is replaced by the following: ‘Existing Active Substances’.

2. In Article 3 the following paragraph 4 is added: ‘4. Annex VII contains the list of active substances which were not identified or notified within the time limits laid down in Regulation (EC) No 1896/2000 and Regulation (EC) No 1687/2002 although there is evidence that they were on the market as active substances in biocidal products before 14 May 2000.’

3.	(a): In paragraph 1 the first subparagraph is replaced by the following: ‘Active substances listed in Annex III and Annex VII shall not be included in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme.’	(a)	In paragraph 1 the first subparagraph is replaced by the following: ‘Active substances listed in Annex III and Annex VII shall not be included in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme.’	(b)	In paragraph 2 the first subparagraph is replaced by the following: ‘Without prejudice to Article 8 of Directive 98/8/EC, the date with effect from which Member States shall, in accordance with Article 16(3) of Directive 98/8/EC, cancel existing authorisations or registrations for biocidal products containing the active substances listed in Annex III and Annex VII, and ensure that such biocidal products are not placed on the market in their territory, shall be 1 September 2006.’	(c)	Paragraph 3 is replaced by the following: ‘From the date of entry into force of this Regulation, any active substance not listed in Annex I or Annex VII shall be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.’
(a)	In paragraph 1 the first subparagraph is replaced by the following: ‘Active substances listed in Annex III and Annex VII shall not be included in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme.’
(b)	In paragraph 2 the first subparagraph is replaced by the following: ‘Without prejudice to Article 8 of Directive 98/8/EC, the date with effect from which Member States shall, in accordance with Article 16(3) of Directive 98/8/EC, cancel existing authorisations or registrations for biocidal products containing the active substances listed in Annex III and Annex VII, and ensure that such biocidal products are not placed on the market in their territory, shall be 1 September 2006.’
(c)	Paragraph 3 is replaced by the following: ‘From the date of entry into force of this Regulation, any active substance not listed in Annex I or Annex VII shall be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.’

4.	The following Articles 4a and 4b are inserted: ‘Article 4a Essential use 1. Member States may apply to the Commission for an extension of the period laid down in Article 4(2) where they consider that an active substance listed in Annex III or VII is essential for them for reasons of health, safety, protection of cultural heritage or is critical for the functioning of society, and where there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health. Applications shall be accompanied by a document stating the reasons and justifications. 2. The applications referred to in paragraph 1 shall be forwarded by the Commission to the other Member States and be made publicly available by electronic means. Member States or any person may for a period of 60 days following reception of an application submit comments in writing to the Commission. 3. Taking account of the comments received, the Commission may in accordance with Article 16(2) of Directive 98/8/EC grant an extension of the period laid down in Article 4(2) of this Regulation for placing the substance on the market of the requesting Member States until 14 May 2010 at the latest, provided that the Member States: (a) ensure that continued use is only possible under the conditions that products containing the substance are approved for the intended essential use; (b) conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment; (c) impose all appropriate risk reduction measures when granting approval; (d) ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and (e) ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC by 14 May 2008 at the latest. 4. The Member States concerned shall annually inform the Commission on the application of paragraph 3 and in particular on the actions taken pursuant to point (e). 5. Member States may at any time review the approvals of biocidal products for which the period of placing on the market has been extended in accordance with paragraph 3. Whenever there is reason to believe that any of the conditions set in points (a) to (e) of that paragraph are no longer satisfied, the Member States concerned shall without undue delay take steps to remedy the situation or if that is not possible, withdraw the approvals of the biocidal products concerned. Article 4b Extension of deadline for placing on the market 1. Producers, formulators, associations or other persons may apply for an extension of the period laid down in Article 4(2) for the marketing of biocidal products containing active substances referred to in that paragraph by submitting a complete dossier for each active substance and product type combination concerned that complies with the requirements of Annex IV to the competent authority in one of the Member States by 1 March 2006 at the latest. 2. The receiving Member State shall verify whether the dossier referred to in paragraph 1 is to be accepted as complete in accordance with Article 9(1) to (4). If the dossier is accepted as complete the active substance/product type combinations shall be included into Annex II and Annex V and, where appropriate, be removed from Annex III or VII. 3. For product types other than 8 and 14, the evaluation of the dossiers shall commence at the same time as the evaluation of dossiers for other active substances in the same product type(s) as specified in Annex V.’	(a)	ensure that continued use is only possible under the conditions that products containing the substance are approved for the intended essential use;	(b)	conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment;	(c)	impose all appropriate risk reduction measures when granting approval;	(d)	ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and	(e)	ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC by 14 May 2008 at the latest.
(a)	ensure that continued use is only possible under the conditions that products containing the substance are approved for the intended essential use;
(b)	conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment;
(c)	impose all appropriate risk reduction measures when granting approval;
(d)	ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and
(e)	ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC by 14 May 2008 at the latest.

5.	(a): In paragraph 2, the following is inserted as third and fourth subparagraphs: ‘The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 1 to 6 and 13 are specified in part C of Annex V. The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 7, 9 to 12, 15, 17, 20, 22 and 23 are specified in part D of Annex V.’	(a)	In paragraph 2, the following is inserted as third and fourth subparagraphs: ‘The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 1 to 6 and 13 are specified in part C of Annex V. The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 7, 9 to 12, 15, 17, 20, 22 and 23 are specified in part D of Annex V.’	(b)	In paragraph 4, ‘1 July 2003’ is replaced by ‘1 March 2005’.
(a)	In paragraph 2, the following is inserted as third and fourth subparagraphs: ‘The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 1 to 6 and 13 are specified in part C of Annex V. The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 7, 9 to 12, 15, 17, 20, 22 and 23 are specified in part D of Annex V.’
(b)	In paragraph 4, ‘1 July 2003’ is replaced by ‘1 March 2005’.

6. In Article 7, the following third paragraph is added: ‘However, any Member State wishing to receive copies only in electronic format or different numbers of copies shall inform the Commission, which shall make that information publicly available by electronic means. If the Member State subsequently decides otherwise, it shall inform the Commission without undue delay, whereupon the Commission shall update accordingly the information made publicly available.’

7. In Article 8(4) the following fourth subparagraph is added: ‘The active substances concerned, the Rapporteur Member States and the new time periods shall be listed in Annex VIII. Annex V shall be updated accordingly.’

8. Annex I is amended in accordance with Annex I to this Regulation.

9. Annex II is replaced by the text set out in Annex II to this Regulation.

10. Annex III is amended in accordance with Annex III to this Regulation.

11. Annex V is amended in accordance with Annex IV to this Regulation.

12. Annex VI is replaced by the text set out in Annex V to this Regulation.

13. The text set out in Annex VI to this Regulation shall be added as Annex VII.

14. The text set out in Annex VII to this Regulation shall be added as Annex VIII.

Article 2

Entry into force

This Regulation shall enter into force on the twentieth day following its publication in the Official Journal of the European Union .

Final provisions

This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 13 June 2005. For the Commission Stavros DIMAS Member of the Commission

¹ OJ L 123, 24.4.1998, p. 1 . Directive as amended by Regulation (EC) No 1882/2003 ( OJ L 284, 31.10.2003, p. 1 ).

² OJ L 307, 24.11.2003, p. 1 .

³ OJ L 228, 8.9.2000, p. 6 . Regulation as amended by Regulation (EC) No 2032/2003.

⁴ OJ L 258, 26.9.2002, p. 15 .

Annex I to Regulation (EC) No 2032/2003 is amended as follows:

1. The CAS number for the substance ‘ Bacillus sphaericus ’ is replaced by ‘143447-72-7’.

2.	\| ‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-tetramethrin \| 214-619-0 \| 1166-46-7’ \|; \| --- \| --- \| --- \|

3.	\| Name (EINECS and/or others) \| EC number \| CAS number \|; \| --- \| --- \| --- \|; \| ‘Ethinylestradiol \| 200-342-2 \| 57-63-6 \|; \| Levonorgestrel \| 212-349-8 \| 797-63-7 \|; \| Tetradecyldimethylbenzylammonium fluoride \| — \| 61134-95-0 \|; \| Terpinol \| — \| 8006-39-1’ \|

‘ANNEX II EXISTING ACTIVE SUBSTANCES AND PRODUCT TYPES INCLUDED IN THE REVIEW PROGRAMME ¹ Name (EINECS and/or others) EC number CAS number PT01 PT02 PT03 PT04 PT05 PT06 PT07 PT08 PT09 PT10 PT11 PT12 PT13 PT14 PT15 PT16 PT17 PT18 PT19 PT20 PT21 PT22 PT23 Formaldehyde 200-001-8 50-00-0 1 2 3 4 5 6 9 11 12 13 18 20 21 22 23 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide 200-076-7 51-03-6 18 19 Bronopol 200-143-0 52-51-7 1 2 3 4 6 7 9 10 11 12 13 22 Diphenoxarsin-10-yl oxide 200-377-3 58-36-6 9 Chlorocresol 200-431-6 59-50-7 1 2 3 4 6 9 10 13 Dichlorvos 200-547-7 62-73-7 18 Ethanol 200-578-6 64-17-5 1 2 3 4 Formic acid 200-579-1 64-18-6 1 2 3 4 5 6 9 11 12 13 18 Benzoic acid 200-618-2 65-85-0 1 2 3 4 6 11 20 Propan-2-ol 200-661-7 67-63-0 1 2 3 4 5 6 9 10 11 12 18 19 Salicylic acid 200-712-3 69-72-7 1 2 3 4 6 Propan-1-ol 200-746-9 71-23-8 1 2 3 4 Ethylene oxide 200-849-9 75-21-8 2 20 1,3-Dibromo-5,5-dimethylhydantoin 201-030-9 77-48-5 2 11 12 Citric acid 201-069-1 77-92-9 2 3 Linalool 201-134-4 78-70-6 19 2-Chloroacetamide 201-174-2 79-07-2 3 6 7 9 10 11 13 Bromoacetic acid 201-175-8 79-08-3 4 Glycollic acid 201-180-5 79-14-1 2 3 4 12 Peracetic acid 201-186-8 79-21-0 1 2 3 4 5 6 11 12 L-(+)-lactic acid 201-196-2 79-33-4 1 2 3 4 6 13 20 Warfarin 201-377-6 81-81-2 14 Anthraquinone 201-549-0 84-65-1 19 Symclosene 201-782-8 87-90-1 2 3 4 5 6 7 9 11 12 Chloroxylenol 201-793-8 88-04-0 1 2 3 4 5 6 Biphenyl-2-ol 201-993-5 90-43-7 1 2 3 4 6 7 9 10 13 Naphthalene 202-049-5 91-20-3 19 Dichlorophen 202-567-1 97-23-4 2 3 4 6 7 9 10 11 12 13 Triclocarban 202-924-1 101-20-2 1 2 4 Geraniol 203-377-1 106-24-1 18 19 1,4-Dichlorobenzene 203-400-5 106-46-7 18 19 Glyoxal 203-474-9 107-22-2 2 3 4 6 12 m-Cresol 203-577-9 108-39-4 2 3 Hexa-2,4-dienoic acid/Sorbic acid 203-768-7 110-44-1 1 2 3 4 5 6 7 8 9 10 Glutaral 203-856-5 111-30-8 1 2 3 4 5 6 7 9 10 11 12 13 22 Nonanoic acid 203-931-2 112-05-0 2 10 Undecan-2-one/Methyl-nonyl-ketone 203-937-5 112-12-9 19 N-(2-Ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide 204-029-1 113-48-4 18 Propoxur 204-043-8 114-26-1 18 1,3-Dichloro-5,5-dimethylhydantoin 204-258-7 118-52-5 2 11 12 Clorophene 204-385-8 120-32-1 1 2 3 4 6 Benzyl benzoate 204-402-9 120-51-4 2 18 19 Benzethonium chloride 204-479-9 121-54-0 1 Malathion 204-497-7 121-75-5 18 Fenitrothion 204-524-2 122-14-5 18 2-Phenoxyethanol 204-589-7 122-99-6 1 2 3 4 6 7 10 11 13 Cetylpyridinium chloride 204-593-9 123-03-5 1 2 3 4 5 6 7 9 20 Octanoic acid 204-677-5 124-07-2 18 19 Carbon dioxide 204-696-9 124-38-9 14 15 18 19 20 Sodium dimethylarsinate 204-708-2 124-65-2 18 Nitromethylidynetrimethanol 204-769-5 126-11-4 2 3 6 11 12 13 Tosylchloramide sodium 204-854-7 127-65-1 1 2 3 4 5 6 9 10 11 Potassium dimethyldithiocarbamate 204-875-1 128-03-0 2 4 6 9 10 11 12 13 Sodium dimethyldithiocarbamate 204-876-7 128-04-1 2 3 4 5 6 9 10 11 12 13 Warfarin sodium 204-929-4 129-06-6 14 Sodium 2-biphenylate 205-055-6 132-27-4 1 2 3 4 6 7 9 10 13 Captan 205-087-0 133-06-2 6 7 9 10 21 N-(Trichloromethylthio)phthalimide/Folpet 205-088-6 133-07-3 6 7 9 10 21 Methyl anthranilate 205-132-4 134-20-3 19 N, N-Diethyl-m-toluamide 205-149-7 134-62-3 19 22 Thiram 205-286-2 137-26-8 2 6 7 9 10 11 12 Ziram 205-288-3 137-30-4 2 6 7 9 10 11 12 19 21 Potassium methyldithiocarbamate 205-292-5 137-41-7 2 9 11 12 Metam-sodium 205-293-0 137-42-8 2 4 6 9 11 12 13 20 Disodium cyanodithiocarbamate 205-346-8 138-93-2 2 9 11 12 1,3-Bis(hydroxymethyl)urea 205-444-0 140-95-4 2 6 9 11 12 13 Nabam 205-547-0 142-59-6 2 4 6 9 10 11 12 13 Sodium hydrogencarbonate 205-633-8 144-55-8 1 3 16 18 19 Thiabendazole 205-725-8 148-79-8 2 6 7 8 9 10 11 12 13 20 21 Benzothiazole-2-thiol 205-736-8 149-30-4 2 7 9 11 12 13 Naled 206-098-3 300-76-5 18 Diuron 206-354-4 330-54-1 6 7 10 21 Diazinon 206-373-8 333-41-5 18 Decanoic acid 206-376-4 334-48-5 18 19 Cyanamide 206-992-3 420-04-2 3 18 2-Hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one 207-880-7 499-44-5 10 Sodium benzoate 208-534-8 532-32-1 1 2 6 11 20 Dazomet 208-576-7 533-74-4 6 7 8 9 10 11 12 (RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS; 1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio 1: 1:1: 1:1: 1:1: 1)/Allethrin 209-542-4 584-79-2 18 Phthalaldehyde 211-402-2 643-79-8 1 2 3 4 6 11 12 13 Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid 211-986-9 731-27-1 7 8 10 21 Hydroxyl-2-pyridone 212-506-0 822-89-9 2 6 9 10 11 12 13 2,6-dimethyl-1,3-dioxan-4-yl acetate 212-579-9 828-00-2 2 6 11 12 13 Terbutryn 212-950-5 886-50-0 7 9 10 Dichlofluanid 214-118-7 1085-98-9 7 8 10 21 Copper thiocyanate 214-183-1 1111-67-7 21 Tetradonium bromide 214-291-9 1119-97-7 1 (1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-tetramethrin 214-619-0 1166-46-7 18 4,5-Dichloro-3H-1,2-dithiol-3-one 214-754-5 1192-52-5 2 6 9 11 12 Diboron trioxide 215-125-8 1303-86-2 8 Zinc sulphide 215-251-3 1314-98-3 7 9 10 18 21 Copper oxide 215-269-1 1317-38-0 8 Dicopper oxide 215-270-7 1317-39-1 21 Disodium tetraborate, anhydrous 215-540-4 1330-43-4 1 2 7 8 9 10 11 13 18 Naphthenic acids, copper salts 215-657-0 1338-02-9 8 2-Butanone, peroxide 215-661-2 1338-23-4 1 2 3 6 9 22 Monolinuron 217-129-5 1746-81-2 2 2,4-Dichlorobenzyl alcohol 217-210-5 1777-82-8 2 6 7 9 10 12 13 Chlorothalonil 217-588-1 1897-45-6 6 7 9 10 21 Fluometuron 218-500-4 2164-17-2 6 7 9 10 11 12 13 21 4-(2-Nitrobutyl)morpholine 218-748-3 2224-44-4 6 13 N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine 219-145-8 2372-82-9 1 2 3 4 6 8 9 10 11 12 13 Tolnaftate 219-266-6 2398-96-1 9 2,2'-Dithiobis[N-methylbenzamide] 219-768-5 2527-58-4 6 7 9 12 13 1,2-Benzisothiazol-3(2H)-one 220-120-9 2634-33-5 2 6 7 9 10 11 12 13 22 2-methyl-2H-isothiazol-3-one 220-239-6 2682-20-4 2 4 6 7 9 10 11 12 13 22 Sulphuryl difluoride 220-281-5 2699-79-8 8 18 Troclosene sodium 220-767-7 2893-78-9 1 2 3 4 5 6 9 11 12 Sodium dichloroisocyanurate dihydrate 220-767-7 51580-86-0 1 2 3 4 5 6 9 11 12 Chlorpyrifos 220-864-4 2921-88-2 18 Mecetronium ethyl sulphate 221-106-5 3006-10-8 1 2 Bis(trichloromethyl) sulphone 221-310-4 3064-70-8 6 9 10 11 12 22 Triclosan 222-182-2 3380-34-5 1 2 3 7 9 Oct-1-ene-3-ol 222-226-0 3391-86-4 19 Sodium 5-chloro-2-[4-chloro-2-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]phenoxy]benzenesulphonate 222-654-8 3567-25-7 18 (Ethylenedioxy)dimethanol 222-720-6 3586-55-8 2 3 4 6 9 11 12 13 Chlorophacinone 223-003-0 3691-35-8 14 Dipyrithione 223-024-5 3696-28-4 9 Sodium 2,4,6-trichlorophenolate 223-246-2 3784-03-0 2 3 6 9 Pyridine-2-thiol 1-oxide, sodium salt 223-296-5 3811-73-2 2 3 4 6 7 9 10 11 12 13 Methenamine 3-chloroallylochloride 223-805-0 4080-31-3 6 9 12 13 2,2',2''-(Hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol 225-208-0 4719-04-4 2 3 4 6 9 11 12 13 Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione 226-408-0 5395-50-6 2 3 4 6 9 10 11 12 13 Chlorpyrifos-methyl 227-011-5 5598-13-0 18 N, N'-methylenebismorpholine 227-062-3 5625-90-1 6 9 11 13 Coumatetralyl 227-424-0 5836-29-3 14 Terbuthylazine 227-637-9 5915-41-3 2 11 12 (R)-p-mentha-1,8-diene 227-813-5 5989-27-5 12 18 19 Methylene dithiocyanate 228-652-3 6317-18-6 6 7 9 10 11 12 13 22 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione 229-222-8 6440-58-0 2 6 11 12 13 (2-bromo-2-nitrovinyl)benzene 230-515-8 7166-19-0 6 11 12 13 Didecyldimethylammonium chloride 230-525-2 7173-51-5 1 2 3 4 6 7 8 9 10 11 12 13 16 18 Prometryn 230-711-3 7287-19-6 6 7 9 10 11 12 13 21 Silver 231-131-3 7440-22-4 2 4 5 9 11 Copper 231-159-6 7440-50-8 2 4 5 11 21 Sulphur dioxide 231-195-2 7446-09-5 1 2 4 5 6 9 11 12 13 20 21 22 Calcium dihexa-2,4-dienoate 231-321-6 7492-55-9 1 3 6 7 9 20 Iodine 231-442-4 7553-56-2 1 2 3 4 5 6 7 9 10 11 21 Polyvinylpyrrolidone iodine Polymer 25655-41-8 1 Silicon dioxide — amorphous 231-545-4 7631-86-9 3 16 18 19 20 Sodium hydrogensulphite 231-548-0 7631-90-5 1 2 4 5 6 9 11 12 13 20 21 22 Hydrogen chloride/Hydrochloric acid 231-595-7 7647-01-0 2 Sodium chloride 231-598-3 7647-14-5 5 Sodium bromide 231-599-9 7647-15-6 2 4 6 7 9 11 12 13 Orthophosphoric acid 231-633-2 7664-38-2 4 Sodium hypochlorite 231-668-3 7681-52-9 1 2 3 4 5 6 11 12 Disodium disulphite 231-673-0 7681-57-4 1 2 4 5 6 9 11 12 13 20 21 22 Tetramethrin 231-711-6 7696-12-0 18 Potassium permanganate 231-760-3 7722-64-7 5 Hydrogen peroxide 231-765-0 7722-84-1 1 2 3 4 5 6 11 12 Nitrogen 231-783-9 7727-37-9 18 7a-Ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole 231-810-4 7747-35-5 6 11 12 13 Sodium sulphite 231-821-4 7757-83-7 1 2 4 5 6 9 11 12 13 20 21 22 Sodium chlorite 231-836-6 7758-19-2 2 3 4 5 11 12 20 Copper sulphate 231-847-6 7758-98-7 2 Silver nitrate 231-853-9 7761-88-8 1 Sodium chlorate 231-887-4 7775-09-9 2 5 11 12 Disodium peroxodisulphate/Sodium persulphate 231-892-1 7775-27-1 4 Calcium hypochlorite 231-908-7 7778-54-3 1 2 3 4 5 11 Chlorine 231-959-5 7782-50-5 2 5 11 Silver chloride 232-033-3 7783-90-6 1 2 3 4 5 6 7 9 10 11 13 Creosote 232-287-5 8001-58-9 8 Bone oil/Animal oil 232-294-3 8001-85-2 19 Rape oil 232-299-0 8002-13-9 18 Pyrethrins and Pyrethroids 232-319-8 8003-34-7 18 19 Garlic ext. 232-371-1 8008-99-9 3 4 5 18 19 Lignin 232-682-2 9005-53-2 1 2 3 4 6 7 9 10 11 12 13 19 21 Boric acid 233-139-2 10043-35-3 1 2 3 6 7 8 9 10 11 12 13 18 22 Chlorine dioxide 233-162-8 10049-04-4 2 3 4 5 11 12 20 Potassium sulphite 233-321-1 10117-38-1 1 2 4 5 6 9 11 12 13 20 21 22 Sodium hydrogen 2,2'-methylenebis[4-chlorophenolate] 233-457-1 10187-52-7 2 3 4 6 7 9 10 11 12 13 2,2-Dibromo-2-cyanoacetamide 233-539-7 10222-01-2 1 2 3 4 5 6 7 9 10 11 12 13 Oxine-copper 233-841-9 10380-28-6 8 Carbendazim 234-232-0 10605-21-7 6 7 9 10 11 12 13 Disodium octaborate tetrahydrate 234-541-0 12280-03-4 1 2 3 6 7 8 9 10 11 12 13 18 Trimagnesium diphosphide 235-023-7 12057-74-8 18 20 23 Copper(II) carbonate-copper(II) hydroxide (1: 1) 235-113-6 12069-69-1 8 Zineb 235-180-1 12122-67-7 21 Ammonium bromide 235-183-8 12124-97-9 2 4 6 7 9 11 12 Hexaboron dizinc undecaoxide/Zinc borate 235-804-2 12767-90-7 9 Pyrithione zinc 236-671-3 13463-41-7 6 7 9 10 13 21 Dodecylguanidine monohydrochloride 237-030-0 13590-97-1 1 2 6 7 9 10 11 12 16 21 22 Potassium 2-biphenylate 237-243-9 13707-65-8 6 9 10 13 Bromine chloride 237-601-4 13863-41-7 2 11 12 (benzyloxy)methanol 238-588-8 14548-60-8 2 6 9 10 11 13 Phoxim 238-887-3 14816-18-3 18 Bis(1-hydroxy-1H-pyridine-2-thionato-O, S)copper 238-984-0 14915-37-8 9 21 Chlorotoluron 239-592-2 15545-48-9 6 7 9 10 11 12 13 21 Sodium p-chloro-m-cresolate 239-825-8 15733-22-9 1 2 3 4 6 9 10 13 Chloralose 240-016-7 15879-93-3 14 15 23 Dipotassium disulphite 240-795-3 16731-55-8 1 2 4 5 6 9 11 12 13 20 21 22 Methomyl 240-815-0 16752-77-5 18 D-gluconic acid, compound with N, N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2: 1) 242-354-0 18472-51-0 1 2 3 4 6 Benzoxonium chloride 243-008-1 19379-90-9 1 9 p-[(Diiodomethyl)sulphonyl]toluene 243-468-3 20018-09-1 6 7 9 10 12 13 Copper dihydroxide 243-815-9 20427-59-2 8 Disilver oxide 243-957-1 20667-12-3 11 Aluminium phosphide 244-088-0 20859-73-8 14 18 20 23 (benzothiazol-2-ylthio)methyl thiocyanate 244-445-0 21564-17-0 2 4 6 7 9 10 11 12 13 Bendiocarb 245-216-8 22781-23-3 18 2-Methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Prallethrin 245-387-9 23031-36-9 18 Potassium (E, E)-hexa-2,4-dienoate 246-376-1 24634-61-5 1 2 3 4 5 6 7 8 9 10 .alpha.,.alpha.',.alpha.''-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol 246-764-0 25254-50-6 2 6 9 11 13 2-Octyl-2H-isothiazol-3-one 247-761-7 26530-20-1 4 6 7 9 10 11 12 13 cis-Tricos-9-ene 248-505-7 27519-02-4 18 19 Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride 248-595-8 27668-52-6 2 7 9 10 21 N'-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine 248-872-3 28159-98-0 7 9 10 21 (S)-3-Allyl-2-methyl-4-oxocyclopent-2-en-1-yl-[1R-[1.alpha.(S*),3.beta.]]-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (only 1R trans, 1S isomer)/S-Bioallethrin 249-013-5 28434-00-6 18 Bioresmethrin 249-014-0 28434-01-7 18 3-[3-(4'-bromo[1,1'-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/Bromadiolone 249-205-9 28772-56-7 14 Pirimiphos-methyl 249-528-5 29232-93-7 18 trans-Isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonate 250-517-2 31218-83-4 18 (Z, E)-Tetradeca-9,12-dienyl acetate 250-753-6 31654-77-0 19 Bromochloro-5,5-dimethylimidazolidine-2,4-dione 251-171-5 32718-18-6 2 3 4 5 6 9 11 12 13 Amitraz 251-375-4 33089-61-1 18 3-(4-Isopropylphenyl)-1,1-dimethylurea/Isoproturon 251-835-4 34123-59-6 6 7 9 10 11 12 13 18 21 N-[[(4-Chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide 252-529-3 35367-38-5 18 1-[2-(Allyloxy)-2-(2,4-Dichlorophenyl)ethyl]-1H-imidazole/Imazalil 252-615-0 35554-44-0 2 3 4 13 20 (±)-1-(.beta.-Allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalil Plant protection product 73790-28-0 2 3 4 13 S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O, O-dimethyl thiophosphate/Azamethiphos 252-626-0 35575-96-3 18 2-Bromo-2-(bromomethyl)pentanedinitrile 252-681-0 35691-65-7 6 7 9 10 11 13 .alpha.-Cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 254-484-5 39515-40-7 18 Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride 255-451-8 41591-87-1 9 Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol 255-953-7 42822-86-6 1 2 19 4,4-Dimethyloxazolidine 257-048-2 51200-87-4 6 11 12 13 Ethyl N-acetyl-N-butyl-.beta.-alaninate 257-835-0 52304-36-6 19 .alpha.-Cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin 257-842-9 52315-07-8 8 9 18 m-Phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin 258-067-9 52645-53-1 2 3 5 8 9 18 19 22 .alpha.-Cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/Deltamethrin 258-256-6 52918-63-5 18 1-Ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Empenthrin 259-154-4 54406-48-3 18 3-Iodo-2-propynyl butylcarbamate 259-627-5 55406-53-6 6 7 8 9 10 11 13 18 Tetrakis(hydroxymethyl)phosphonium sulphate (2: 1) 259-709-0 55566-30-8 2 6 9 11 12 3-(3-Biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum 259-978-4 56073-07-5 14 4-Hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/Brodifacoum 259-980-5 56073-10-0 14 1-[[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole 262-104-4 60207-90-1 1 2 4 7 8 9 10 12 13 20 4,5-Dichloro-2-octyl-2H-isothiazol-3-one 264-843-8 64359-81-5 6 7 9 10 11 12 21 2-Chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide 264-980-3 64628-44-0 18 3,3'-Methylenebis[5-methyloxazolidine]/Oxazolidin 266-235-8 66204-44-2 2 6 10 11 12 13 N-Cyclopropyl-1,3,5-triazine-2,4,6-triamine 266-257-8 66215-27-8 18 cis-4-[3-(p-tert-Butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine 266-719-9 67564-91-4 6 7 8 9 10 12 13 21 .alpha.-Cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cyfluthrin 269-855-7 68359-37-5 18 Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides 269-919-4 68391-01-5 1 2 3 4 5 6 7 9 10 11 12 13 16 17 18 19 21 22 Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides 270-325-2 68424-85-1 1 2 3 4 6 7 8 9 10 11 12 13 18 19 21 Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides 270-331-5 68424-95-3 1 2 3 4 5 6 7 9 10 11 12 13 16 22 Fatty acids, coco, reaction products with diethanolamine 270-430-3 68440-04-0 3 Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1: 1) 273-545-7 68989-01-5 2 4 11 12 Sodium N-(hydroxymethyl)glycinate 274-357-8 70161-44-3 6 7 Amines, C10-16-alkyldimethyl, N-oxides 274-687-2 70592-80-2 1 2 Pentapotassium bis(peroxymonosulphate) bis(sulphate) 274-778-7 70693-62-8 1 2 3 4 5 11 12 N, N'-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride 274-861-8 70775-75-6 1 1,3-didecyl-2-methyl-1H-imidazolium chloride 274-948-0 70862-65-6 2 3 4 6 7 10 11 12 13 1-[1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea 278-928-2 78491-02-8 6 7 Magnesium-monoperoxyphthalat-hexahydrate 279-013-0 84665-66-7 2 3 4 Tributyltetradecylphosphonium chloride 279-808-2 81741-28-8 2 4 9 11 12 Margosa ext. 283-644-7 84696-25-3 18 19 Tar acids, polyalkylphenol fraction 284-893-4 84989-05-9 2 3 Melaleuca alternifolia , ext./Australian tea tree oil 285-377-1 85085-48-9 1 2 3 19 2,4,8,10-Tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d, g][1,3,2]dioxaphosphocin 6-oxide, sodium salt 286-344-4 85209-91-2 1 Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides 287-089-1 85409-22-9 1 2 3 4 5 6 7 9 10 11 12 13 16 17 18 19 21 22 Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides 287-090-7 85409-23-0 1 2 3 4 5 6 9 11 12 13 16 17 18 19 21 22 .alpha.-Cyano-4-fluoro-3-phenoxybenzyl [1.alpha.(S*),3.alpha.]-(±)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 289-244-9 86560-93-2 18 Chrysanthemum cinerariaefolium , ext. 289-699-3 89997-63-7 18 19 Urea, N,N'-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde 292-348-7 90604-54-9 2 6 11 12 13 Juniper, Juniperus mexicana , ext. 294-461-7 91722-61-1 19 Lavender, Lavandula hybrida , ext./Lavandin oil 294-470-6 91722-69-9 18 19 Pine ext. 304-455-9 94266-48-5 10 Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts 309-206-8 100085-64-1 1 2 3 4 6 7 10 11 12 13 Corn cob, powdered 310-127-6 999999-99-4 14 1-(3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/Hexaflumuron 401-400-1 86479-06-3 18 1,3-Dichloro-5-ethyl-5-methylimidazolidine-2,4-dione 401-570-7 89415-87-2 2 11 12 1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole 403-640-2 107534-96-3 7 8 9 10 Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine 403-950-8 164907-72-6 1 2 3 4 18 Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate 404-690-8 68132-19-4 9 2,3,5,6-Tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/Transfluthrin 405-060-5 118712-89-3 18 5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon 405-090-9 67485-29-4 18 3-Phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox 407-980-2 80844-07-1 2 3 8 18 6-(Phthalimido)peroxyhexanoic acid 410-850-8 128275-31-0 1 2 3 4 11 12 Methyl neodecanamide 414-460-9 105726-67-8 19 Mixture of: alpha-Cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate; alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrin 415-130-7 91465-08-6 18 1-(4-(2-Chloro-.alpha.,.alpha.,.alpha.-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/Flufenoxuron 417-680-3 101463-69-8 8 18 5-Chloro-2-(4-chlorphenoxy)phenol 418-890-8 3380-30-1 1 2 4 6 9 2-Butyl-benzo[d]isothiazol-3-one 420-590-7 4299-07-4 6 7 9 10 13 Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen 421-960-0 90035-08-8 14 sec-Butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine 423-210-8 119515-38-7 19 Fipronil 424-610-5 120068-37-3 18 cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride 426-020-3 51229-78-8 6 9 12 13 1-(6-Chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid 428-040-8 138261-41-3 18 Thiamethoxam 428-650-4 153719-23-4 8 9 18 [2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/Imiprothrin 428-790-6 72963-72-5 18 2-(1-Methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen 429-800-1 95737-68-1 18 3-Benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide 431-030-6 163269-30-5 4 6 7 9 10 13 21 Reaction products of diisopropanolamine with formaldehyde (1: 4) 432-440-8 220444-73-5 6 13 Chloromethyl n-octyl disulfide 432-680-3 180128-56-7 21 Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succiante with hydrogen peroxide/Perestane 432-790-1 1 2 3 4 5 11 12 Bis(3-aminopropyl)-octylamine 433-340-7 86423-37-2 2 3 4 11 12 13 (E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine 433-460-1 210880-92-5 3 8 18 (E)-2-Octadecenal Not yet allocated 51534-37-3 19 (E, Z)-2,13-Octadecadienal Not yet allocated 99577-57-8 19 Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing Not yet allocated 398477-47-9 1 2 6 7 9 Silver sodium hydrogen zirconium phosphate Not yet allocated 1 2 3 4 7 9 10 Peroxyoctanoic acid 33734-57-5 2 3 4 11 12 Cyclohexylhydroxydiazene 1-oxide, potassium salt 66603-10-9 5 6 7 8 9 10 11 12 13 Silica, amorphous, crystalline-free 112945-52-5 18 Bis[1-cyclohexyl-1,2-di(hydroxyl-.kappa.O)diazeniumato(2-)]copper 312600-89-8 2 6 7 8 9 10 11 12 21 Silver zeolite A 2 4 5 7 9 Silicium dioxide/Kieselguhr Plant Protection Product 61790-53-2 18 S-Methoprene/Isopropyl (S-(E, E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate Plant protection product 65733-16-6 18 S-Hydroprene/Ethyl (S-(E, E))-3,7,11-trimethyldodeca-2,4-dienoate Plant protection product 65733-18-8 18 Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate Plant protection product 66230-04-4 18 [1.alpha.(S*),3.alpha.]-(.alpha.)-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-cypermethrin Plant protection product 67375-30-8 6 9 18 Abamectin (Mixture of avermectin B1a; > 80 % EINECS 265-610-3, and avermectin B1b; < 20 % EINECS 265-611-9) Plant protection product 71751-41-2 16 18 Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1’-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/Biphenate Plant protection product 82657-04-3 8 18 3-(3-(4’-Bromo-(1,1’-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS; 1RS,3SR)-3-(4'-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/Difethialone Plant protection product 104653-34-1 14 Guazatine triacetate Plant protection product 115044-19-4 2 8 4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr Plant protection product 122453-73-0 6 7 8 9 10 12 13 18 21 Aluminium sodium silicate-silver complex/Silver zeolite Plant protection product 130328-18-6 6 7 13 Aluminium sodium silicate-silver zinc complex/Silver-zinc-zeolite Plant protection product 130328-20-0 1 2 6 7 9 3-phenoxybenzyl (1R)-cis, trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Phenothrin Plant protection product 188023-86-1 18 Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (16,0 %), 5-Hydroxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-547-6; 28,8 %) and 5-Hydroxypoly(methyleneoxy) methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (5,2 %) in water (50 %) Plant protection product 6 13 S-Cyphenothrin Plant protection product 18 (RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS; 1:1)/d-trans-Allethrin Plant protection product 18 (RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R; 1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers: 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S; 4:4: 1:1)/d-Allethrin Plant protection product 18 (RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1R/S; 1:3)/Esbiothrin Plant protection product 18 Spinosad: fermentation product of soil bacteria containing Spinosyn A and Spinosyn D Plant protection product 3 18 Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride Polymer 25988-97-0 2 11 12 Homopolymer of 2-tert-butylaminoethyl methacrylate (EINECS 223-228-4) Polymer 26716-20-1 2 4 5 6 7 9 10 11 12 13 21 Polymer of formaldehyde and acrolein Polymer 26781-23-7 3 Monohydrochloride of polymer of N, N'''-1,6-hexanediylbis[N'-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 240-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride) Polymer 27083-27-8 1 2 3 4 5 6 9 11 12 22 N, N,N',N' — Tetramethylethylenediamine-bis(2-chloroethyl) ether copolymer Polymer 31075-24-8 2 9 11 12 13 Poly-(hexamethylendiamine guanidinium chloride) Polymer 57028-96-3 1 2 3 4 5 6 7 9 10 11 12 13 20 21 Polyhexamethylene biguanide Polymer 91403-50-8 1 2 3 4 9 10 11 Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt) Polymer 94667-33-1 2 3 4 6 8 9 10 11 12 13 Copolymer of 2-propenal and propane-1,2-diol Polymer 191546-07-3 6 7 10 13 N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate Polymer 214710-34-6 2 6 8 9 10 11 12 13 Oligo-(2-(2-ethoxy)ethoxyethyl guanidinium chloride) Polymer 374572-91-5 1 2 3 4 5 6 7 9 10 11 12 13 20 21 Sodium lignosulfonate Natural polymer 8061-51-6 12 Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6) Mixture 55965-84-9 2 3 4 6 7 9 10 11 12 13 Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid Mixture 139734-65-9 1 2 3 4 6 7 10 11 12 13 Quaternary ammonium iodides Mixture 308074-50-2 1 2 3 4 5 6 7 Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4) Mixture 1 2 3 4 6 7 10 11 13 Active chlorine: mixture of hypochlorous acid and sodium hypochlorite produced in situ Mixture 2 3 4 5 Potassium salts of fatty acids (C15-21) Mixture 2 18 Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22 saturated and unsaturated, and tallow alkyl, coco alkyl and soya alkyl) chlorides, bromides, or hydroxides)/BKC Mixture of EINECS listed substances 1 2 3 4 6 7 8 9 10 11 12 13 Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18 saturated and unsaturated, and tallow alkyl, coco alkyl and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC Mixture of EINECS listed substances 1 2 3 4 6 7 8 9 10 11 12 13 Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18 saturated and unsaturated, and tallow alkyl, coco alkyl and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC Mixture of EINECS listed substances 8 Bacillus sphaericus Micro-organism 143447-72-7 2 18 Bacillus thuringiensis subsp. Israelensis Serotype H14 Micro-organism 2 5 18 Bacillus subtilis Micro-organism 3’

¹ Contact details of participants are specified at http://ecb.jrc.it/biocides.

Annex III to Regulation (EC) No 2032/2003 is amended as follows:

1. The title is replaced by the following:

| Name (EINECS and/or others) | EC number | CAS number |; | --- | --- | --- |; | ‘Bis(tributyltin) oxide | 200-268-0 | 56-35-9 |; | Ethinylestradiol | 200-342-2 | 57-63-6 |; | .gamma.-HCH or .gamma.-BHC/Lindane/1,2,3,4,5,6-hexachlorocyclohexane | 200-401-2 | 58-89-9 |; | Dimethoate | 200-480-3 | 60-51-5 |; | Diphacinone | 201-434-5 | 82-66-6 |; | Sodium pentachlorophenolate | 205-025-2 | 131-52-2 |; | Levonorgestrel | 212-349-8 | 797-63-7 |; | Diarsenic pentaoxide | 215-116-9 | 1303-28-2 |; | Zinc oxide | 215-222-5 | 1314-13-2 |; | Trizinc diphosphide | 215-244-5 | 1314-84-7 |; | Chromium trioxide | 215-607-8 | 1333-82-0 |; | 2-Bromo-1-(4-hydroxyphenyl)ethan-1-one | 219-655-0 | 2491-38-5 |; | Sodium dichromate | 234-190-3 | 10588-01-9 |; | Hexafluorosilicic acid | 241-034-8 | 16961-83-4 |; | Ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb | 276-696-7 | 72490-01-8 |; | Stannane, tributyl-, mono(naphthenoyloxy) derivs. | 287-083-9 | 85409-17-2 |; | .alpha.,.alpha.,.alpha.-Trifluoro-N-methyl-4,6-dinitro-N-(2,4,6-tribromophenyl)-o-toluidine/Bromethalin | Plant Protection Product | 63333-35-7 |; | Tetradecyldimethylbenzylammonium fluoride | — | 61134-95-0 |; | Terpinol | — | 8006-39-1’ |

Annex V to Regulation (EC) No 2032/2003 is amended as follows:

1.	\| ‘Naphthenic acids, copper salts \| 215-657-0 \| 1338-02-9 \|; \| --- \| --- \| --- \|; \| Oxine-copper \| 233-841-9 \| 10380-28-6 \|; \| .alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin \| 257-842-9 \| 52315-07-8’ \|

| ‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-tetramethrin | 214-619-0 | 1166-46-7 | D |; | --- | --- | --- | --- |; | Sulphur dioxide | 231-195-2 | 7446-09-5 | D |; | Tetramethrin | 231-711-6 | 7696-12-0 | D |; | Potassium sulphite | 233-321-1 | 10117-38-1 | D |; | Dipotassium disulphite | 240-795-3 | 16731-55-8 | D’ |

| Name (EINECS and/or others) | EC number | CAS number | |; | --- | --- | --- | --- |; | 5-Chloro-2-(4-chlorphenoxy)phenol | 418-890-8 | 3380-30-1 | AT |; | Formic acid | 200-579-1 | 64-18-6 | BE |; | Chloroxylenol | 201-793-8 | 88-04-0 | BE |; | Benzethonium chloride | 204-479-9 | 121-54-0 | BE |; | Silver chloride | 232-033-3 | 7783-90-6 | CY |; | Benzoxonium chloride | 243-008-1 | 19379-90-9 | CY |; | Formaldehyde | 200-001-8 | 50-00-0 | DE |; | Benzoic acid | 200-618-2 | 65-85-0 | DE |; | Propan-2-ol | 200-661-7 | 67-63-0 | DE |; | Propan-1-ol | 200-746-9 | 71-23-8 | DE |; | L-(+)-lactic acid | 201-196-2 | 79-33-4 | DE |; | Hexa-2,4-dienoic acid/Sorbic acid | 203-768-7 | 110-44-1 | DE |; | Sodium benzoate | 208-534-8 | 532-32-1 | DE |; | Sulphur dioxide | 231-195-2 | 7446-09-5 | DE |; | Calcium dihexa-2,4-dienoate | 231-321-6 | 7492-55-9 | DE |; | Sodium hydrogensulphite | 231-548-0 | 7631-90-5 | DE |; | Disodium disulphite | 231-673-0 | 7681-57-4 | DE |; | Sodium sulphite | 231-821-4 | 7757-83-7 | DE |; | Potassium sulphite | 233-321-1 | 10117-38-1 | DE |; | Dipotassium disulphite | 240-795-3 | 16731-55-8 | DE |; | Potassium (E, E)-hexa-2,4-dienoate | 246-376-1 | 24634-61-5 | DE |; | Reaction products of: glutamic acid and N-(C12-14-alkyl) propylenediamine | 403-950-8 | 164907-72-6 | DE |; | Triclosan | 222-182-2 | 3380-34-5 | DK |; | 2,2-Dibromo-2-cyanoacetamide | 233-539-7 | 10222-01-2 | DK |; | Peracetic acid | 201-186-8 | 79-21-0 | EE |; | Ethanol | 200-578-6 | 64-17-5 | EL |; | Sodium hydrogencarbonate | 205-633-8 | 144-55-8 | EL |; | Lignin | 232-682-2 | 9005-53-2 | EL |; | Bronopol | 200-143-0 | 52-51-7 | ES |; | Biphenyl-2-ol | 201-993-5 | 90-43-7 | ES |; | Sodium 2-biphenylate | 205-055-6 | 132-27-4 | ES |; | Dodecylguanidine monohydrochloride | 237-030-0 | 13590-97-1 | ES |; | Melaleuca alternifolia, ext./Australian tea tree oil | 285-377-1 | 85085-48-9 | ES |; | Quaternary ammonium iodides | Mixture | 308074-50-2 | ES |; | Aluminium sodium silicate-silver zinc complex/Silver-zinc-zeolite | Plant protection product | 130328-20-0 | ES |; | Glutaral | 203-856-5 | 111-30-8 | FI |; | Hydrogen peroxide | 231-765-0 | 7722-84-1 | FI |; | 1-[[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole | 262-104-4 | 60207-90-1 | FI |; | Chlorocresol | 200-431-6 | 59-50-7 | FR |; | Phthalaldehyde | 211-402-2 | 643-79-8 | FR |; | Sodium p-chloro-m-cresolate | 239-825-8 | 15733-22-9 | FR |; | Monohydrochloride of polymer of N, N'''-1,6-hexanediylbis[N'-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 240-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride) | Polymer | 27083-27-8 | FR |; | Oligo-(2-(2-ethoxy)ethoxyethyl guanidinium chloride) | Polymer | 374572-91-5 | FR |; | Poly-(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | FR |; | Polyhexamethylene biguanide | Polymer | 91403-50-8 | FR |; | 2-Butanone, peroxide | 215-661-2 | 1338-23-4 | HU |; | N, N'-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene) bis(octylammonium) dichloride | 274-861-8 | 70775-75-6 | HU |; | Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succiante with hydrogen peroxide/Perestane | 432-790-1 | | HU |; | Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing | Not yet allocated | 398477-47-9 | HU |; | Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid | Mixture | 139734-65-9 | IE |; | Didecyldimethylammonium chloride | 230-525-2 | 7173-51-5 | IT |; | Sodium hypochlorite | 231-668-3 | 7681-52-9 | IT |; | Calcium hypochlorite | 231-908-7 | 7778-54-3 | IT |; | Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides | 269-919-4 | 68391-01-5 | IT |; | Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides | 270-325-2 | 68424-85-1 | IT |; | Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides | 270-331-5 | 68424-95-3 | IT |; | Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides | 287-089-1 | 85409-22-9 | IT |; | Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides | 287-090-7 | 85409-23-0 | IT |; | 6-(Phthalimido)peroxyhexanoic acid | 410-850-8 | 128275-31-0 | IT |; | Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22 saturated and unsaturated, and tallow alkyl, coco alkyl and soya alkyl) chlorides, bromides, or hydroxides)/BKC | Mixture of EINECS listed substances | | IT |; | Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18 saturated and unsaturated, and tallow alkyl, coco alkyl and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC | Mixture of EINECS listed substances | | IT |; | Salicylic acid | 200-712-3 | 69-72-7 | LT |; | Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts | 309-206-8 | 100085-64-1 | LT |; | Polyvinylpyrrolidone iodine | Polymer | 25655-41-8 | LV |; | 2,4,8,10-Tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d, g][1,3,2]dioxaphosphocin 6-oxide, sodium salt | 286-344-4 | 85209-91-2 | MT |; | Disodium tetraborate, anhydrous | 215-540-4 | 1330-43-4 | NL |; | Boric acid | 233-139-2 | 10043-35-3 | NL |; | Disodium octaborate tetrahydrate | 234-541-0 | 12280-03-4 | NL |; | Mecetronium ethyl sulphate | 221-106-5 | 3006-10-8 | PL |; | Silver sodium hydrogen zirconium phosphate | Not yet allocated | | PL |; | N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine | 219-145-8 | 2372-82-9 | PT |; | D-gluconic acid, compound with N, N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2: 1) | 242-354-0 | 18472-51-0 | PT |; | Amines, C10-16-alkyldimethyl, N-oxides | 274-687-2 | 70592-80-2 | PT |; | Tosylchloramide sodium | 204-854-7 | 127-65-1 | SE |; | Iodine | 231-442-4 | 7553-56-2 | SE |; | Pentapotassium bis(peroxymonosulphate) bis(sulphate) | 274-778-7 | 70693-62-8 | SI |; | Triclocarban | 202-924-1 | 101-20-2 | SK |; | Silver nitrate | 231-853-9 | 7761-88-8 | SK |; | 2-Phenoxyethanol | 204-589-7 | 122-99-6 | UK |; | Cetylpyridinium chloride | 204-593-9 | 123-03-5 | UK |; | Troclosene sodium | 220-767-7 | 2893-78-9 | UK |; | Sodium dichloroisocyanurate dihydrate | 220-767-7 | 51580-86-0 | UK |; | Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol | 255-953-7 | 42822-86-6 | UK |; | Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4) | Mixture | | UK |; | Clorophene | 204-385-8 | 120-32-1 | N |; | Tetradonium bromide | 214-291-9 | 1119-97-7 | N |

| Name (EINECS and/or others) | EC Number | CAS Number | |; | --- | --- | --- | --- |; | Sodium N-(hydroxymethyl)glycinate | 274-357-8 | 70161-44-3 | AT |; | Cyclohexylhydroxydiazene 1-oxide, potassium salt | | 66603-10-9 | AT |; | Bis[1-cyclohexyl-1,2-di(hydroxyl-.kappa.O)diazeniumato(2-)]copper | | 312600-89-8 | AT |; | Thiram | 205-286-2 | 137-26-8 | BE |; | Ziram | 205-288-3 | 137-30-4 | BE |; | Dazomet | 208-576-7 | 533-74-4 | BE |; | Silver chloride | 232-033-3 | 7783-90-6 | CY |; | 2,4-Dichlorobenzyl alcohol | 217-210-5 | 1777-82-8 | CZ |; | 2-Bromo-2-(bromomethyl)pentanedinitrile | 252-681-0 | 35691-65-7 | CZ |; | 1,3-didecyl-2-methyl-1H-imidazolium chloride | 274-948-0 | 70862-65-6 | CZ |; | 2-Butyl-benzo[d]isothiazol-3-one | 420-590-7 | 4299-07-4 | CZ |; | Hexa-2,4-dienoic acid/Sorbic acid | 203-768-7 | 110-44-1 | DE |; | Calcium dihexa-2,4-dienoate | 231-321-6 | 7492-55-9 | DE |; | Carbendazim | 234-232-0 | 10605-21-7 | DE |; | Potassium (E, E)-hexa-2,4-dienoate | 246-376-1 | 24634-61-5 | DE |; | 3-(4-Isopropylphenyl)-1,1-dimethylurea/Isoproturon | 251-835-4 | 34123-59-6 | DE |; | Diuron | 206-354-4 | 330-54-1 | DK |; | Triclosan | 222-182-2 | 3380-34-5 | DK |; | 2,2-Dibromo-2-cyanoacetamide | 233-539-7 | 10222-01-2 | DK |; | 3-Iodo-2-propynyl butylcarbamate | 259-627-5 | 55406-53-6 | DK |; | 1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole | 403-640-2 | 107534-96-3 | DK |; | 2-Chloroacetamide | 201-174-2 | 79-07-2 | EE |; | Fluometuron | 218-500-4 | 2164-17-2 | EL |; | Lignin | 232-682-2 | 9005-53-2 | EL |; | Bronopol | 200-143-0 | 52-51-7 | ES |; | Biphenyl-2-ol | 201-993-5 | 90-43-7 | ES |; | Sodium 2-biphenylate | 205-055-6 | 132-27-4 | ES |; | Thiabendazole | 205-725-8 | 148-79-8 | ES |; | 1,2-Benzisothiazol-3(2H)-one | 220-120-9 | 2634-33-5 | ES |; | Dodecylguanidine monohydrochloride | 237-030-0 | 13590-97-1 | ES |; | Chlorotoluron | 239-592-2 | 15545-48-9 | ES |; | Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride | 248-595-8 | 27668-52-6 | ES |; | cis-4-[3-(p-tert-Butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine | 266-719-9 | 67564-91-4 | ES |; | Quaternary ammonium iodides | Mixture | 308074-50-2 | ES |; | Aluminium sodium silicate-silver complex/Silver zeolite | Plant protection product | 130328-18-6 | ES |; | Aluminium sodium silicate-silver zinc complex/Silver-zinc-zeolite | Plant protection product | 130328-20-0 | ES |; | Silver zeolite A | | | ES |; | Glutaral | 203-856-5 | 111-30-8 | FI |; | Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid | 211-986-9 | 731-27-1 | FI |; | 1-[[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole | 262-104-4 | 60207-90-1 | FI |; | Methylene dithiocyanate | 228-652-3 | 6317-18-6 | FR |; | Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6) | Mixture | 55965-84-9 | FR |; | Oligo-(2-(2-ethoxy)ethoxyethyl guanidinium chloride) | Polymer | 374572-91-5 | FR |; | Poly-(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | FR |; | Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing | Not yet allocated | 398477-47-9 | HU |; | Copolymer of 2-propenal and propane-1,2-diol | Polymer | 191546-07-3 | HU |; | Dichlorophen | 202-567-1 | 97-23-4 | IE |; | Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid | Mixture | 139734-65-9 | IE |; | Captan | 205-087-0 | 133-06-2 | IT |; | N-(Trichloromethylthio)phthalimide/Folpet | 205-088-6 | 133-07-3 | IT |; | Didecyldimethylammonium chloride | 230-525-2 | 7173-51-5 | IT |; | Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides | 269-919-4 | 68391-01-5 | IT |; | Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides | 270-325-2 | 68424-85-1 | IT |; | Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides | 270-331-5 | 68424-95-3 | IT |; | Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides | 287-089-1 | 85409-22-9 | IT |; | Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22 saturated and unsaturated, and tallow alkyl, coco alkyl and soya alkyl) chlorides, bromides, or hydroxides)/BKC | Mixture of EINECS listed substances | | IT |; | Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18 saturated and unsaturated, and tallow alkyl, coco alkyl and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC | Mixture of EINECS listed substances | | IT |; | 1-[1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea | 278-928-2 | 78491-02-8 | LT |; | Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts | 309-206-8 | 100085-64-1 | LT |; | Sodium hydrogen 2,2'-methylenebis[4-chlorophenolate] | 233-457-1 | 10187-52-7 | LV |; | Disodium tetraborate, anhydrous | 215-540-4 | 1330-43-4 | NL |; | Chlorothalonil | 217-588-1 | 1897-45-6 | NL |; | Sodium bromide | 231-599-9 | 7647-15-6 | NL |; | Boric acid | 233-139-2 | 10043-35-3 | NL |; | Disodium octaborate tetrahydrate | 234-541-0 | 12280-03-4 | NL |; | N'-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine | 248-872-3 | 28159-98-0 | NL |; | 2,2'-Dithiobis[N-methylbenzamide] | 219-768-5 | 2527-58-4 | PL |; | Silver sodium hydrogen zirconium phosphate | Not yet allocated | | PL |; | Prometryn | 230-711-3 | 7287-19-6 | PT |; | 3-Benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide | 431-030-6 | 163269-30-5 | PT |; | 4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr | Plant protection product | 122453-73-0 | PT |; | Pyridine-2-thiol 1-oxide, sodium salt | 223-296-5 | 3811-73-2 | SE |; | Iodine | 231-442-4 | 7553-56-2 | SE |; | Ammonium bromide | 235-183-8 | 12124-97-9 | SE |; | Pyrithione zinc | 236-671-3 | 13463-41-7 | SE |; | 2-methyl-2H-isothiazol-3-one | 220-239-6 | 2682-20-4 | SI |; | Terbutryn | 212-950-5 | 886-50-0 | SK |; | Symclosene | 201-782-8 | 87-90-1 | UK |; | 2-Phenoxyethanol | 204-589-7 | 122-99-6 | UK |; | Cetylpyridinium chloride | 204-593-9 | 123-03-5 | UK |; | Dichlofluanid | 214-118-7 | 1085-98-9 | UK |; | Zinc sulphide | 215-251-3 | 1314-98-3 | UK |; | p-[(Diiodomethyl)sulphonyl]toluene | 243-468-3 | 20018-09-1 | UK |; | 2-Octyl-2H-isothiazol-3-one | 247-761-7 | 26530-20-1 | UK |; | Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4) | Mixture | | UK |; | Homopolymer of 2-tert-butylaminoethyl methacrylate (EINECS 223-228-4) | Polymer | 26716-20-1 | UK |; | Benzothiazole-2-thiol | 205-736-8 | 149-30-4 | N |; | (benzothiazol-2-ylthio)methyl thiocyanate | 244-445-0 | 21564-17-0 | N |; | 4,5-Dichloro-2-octyl-2H-isothiazol-3-one | 264-843-8 | 64359-81-5 | N |

‘ANNEX VI COMPETENT AUTHORITIES, AS REFERRED TO IN ARTICLE 5(4) AS OF 1 MARCH 2005 BELGIUM Federal Public Service Health, Food chain safety and Environment, General Directorate: Environment Eurostation Victor Hortaplace 40, box 10 B-1060 Brussels CZECH REPUBLIC Ministry of Health of the Czech Republic Chemical substances Register Palackeho namesti 4 CZ-128 01 Prague 2 DENMARK Danish Environmental Protection Agency — Miljøstyrelsen Strandgade 29 DK-1401 København K GERMANY Bundesanstalt für Arbeitsschutz und Arbeitsmedizin Fachbereich 5 Friedrich-Henkel-Weg 1-25 D-44149 Dortmund ESTONIA Chemicals Notification Centre Gonsiori 29 EE-15027 Tallinn GREECE National Organisation for Medicines (Product Types: 1-7, 11, 20, 22) 284 Messogion Av. GR-15562 Cholargos Athens Ministry of Agricultural Development and Food General Directorate of Plant Produce (Product Types: 8-10, 12-19, 21, 23) 150 Syngrou Av, Kallithea GR-17671 Athens SPAIN Ministerio de Sanidad y Consumo Dirección General de Salud Pública Paseo del Prado, 18-20 ES-28071 Madrid FRANCE Ministère de l'Écologie et du Développement durable Bureau des Substances et Préparations Chimiques 20 Avenue de Ségur F-75302 Paris 07 SP IRELAND Pesticide Control Service Dept of Agriculture and Food Abbotstown, Castleknock Dublin 15 Ireland ITALY Ministry of Health Directorate-General for the Assessment of Medicinal Products and Drugs Surveillance Ufficio VII Piazzale dell'Industria, 20 I-00144 Roma CYPRUS Department of Agriculture Corner of Navarinou Str. & Saripolou Str., 2 nd floor Ayios Dometios CY-1100 Lefkosia (Nicosia) LATVIA Latvian Environment, Geology and Meteorology Agency Maskavas iela 165 LV-1019 Riga LITUANIA State Environmental Health Centre Kalvariju str. 153 LT-2042 Vilnius LUXEMBOURG Ministère de la Santé L-2935 Luxemburgo HUNGARY National Public Health and Medical Officer's Service Office of the Chief Medical Officer of State (Állami Népegészségügyi és Tisztiorvosi Szolgálat Országos Tisztifőorvosi Hivatal) Gyáli u. 2-6 H-1097 Budapest MALTA Plant Health Departement Plant Biotechnology Centre Annibale Preca Street MT-Lija BZN 04 NETHERLANDS College voor de toelating van bestrijdingsmiddelen (Ctb) Stadsbrink 5 6707 AA Wageningen Nederland AUSTRIA Bundesministerium für Land- und Forstwirtschaft, Umwelt und Wasserwirtschaft Abteilung V/3 Stubenbastei 5 A-1010 Wien POLAND Office for Registration of Medicinal Products, Medical Devices and Biocidal Products Ząbkowska 41 PL-03-736 Warsaw PORTUGAL Direccão-Geral da Saúde (Tipos de produtos: à excepção 3 e 8) Alameda D. Afonso Henriques, 45 P-1049-005 Lisboa Direcção-Geral de Protecção das Culturas (Tipos de produtos: 8) Quinta do Marquês, P-2780-155 Oeiras Direccão-Geral de Veterinária (Tipos de produtos: 3) Largo da Academia Nacional das Belas Artes, 2 P-1249-105 Lisboa SLOVENIA National Chemicals Bureau Ministry of Health Mali trg 6 SI-1000 Ljubljana SLOVAKIA Centre for Chemical Substances and Preparations Limbova 14 SK-833 01 Bratislava FINLAND Suomen ympäristökeskus (Product Types: 8, 10-12, 14-17, 21, 23) Mechelininkatu 34 a FIN-00251 Helsinki Sosiaali- ja terveydenhuollon tuotevalvontakeskus (Product Types: 1-7, 9, 13, 18-20, 22) Säästöpankinranta 2 A FIN-00531 Helsinki SWEDEN Kemikalieinspektionen PO Box 2 SE-172 13 Sundbyberg UNITED KINGDOM Health & Safety Executive Magdalen House Bootle Merseyside L20 3QZ United Kingdom ICELAND Environment and Food Agency of Iceland Sudurlandsbraut 24 IS-108 Reikiavik NORWAY Norwegian Pollution Control Authority Strømsveien 96 N-0663 Oslo’

‘ANNEX VII EXISTING ACTIVE SUBSTANCES THAT WERE NOT IDENTIFIED BY 28 MARCH 2002 BUT MAY REMAIN ON THE MARKET UNTIL 1 SEPTEMBER 2006 Name (EINECS and/or others) EC number CAS number Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime 215-137-3 1305-62-0 Calcium oxide/lime/burnt lime/quicklime 215-138-9 1305-78-8 Ammonium tetrafluoroborate 237-531-4 13826-83-0 Calcium magnesium oxide/dolomitic lime 253-425-0 37247-91-9 Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic lime 254-454-1 39445-23-3 Shale oils 269-646-0 68308-34-9 2-bromo-1-(2,4-dichlorophenyl)vinyl diethyl phosphate/bromfenvinfos Plant Protection Product 33399-00-7’

‘ANNEX VIII EXISTING ACTIVE SUBSTANCES THAT WERE NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH ANOTHER PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANT Name (EINECS and/or others) EC number CAS number Product type Rapporteur Member State New deadline for dossier submission Naphthenic acids, copper salts 215-657-0 1338-02-9 8 UK 31.3.2006 Oxine-copper 233-841-9 10380-28-6 8 DE 31.3.2006 .alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin 257-842-9 52315-07-8 8 BE 31.3.2006’

Contact details of participants are specified at http://ecb.jrc.it/biocides. ↩ ↩² ↩³ ↩⁴
. ↩ ↩²
. Regulation as amended by Regulation (EC) No 2032/2003. ↩ ↩²
. ↩ ↩²

Preamble

Article 1

Article 2

Final provisions

Footnotes